rs149171124

Variant summary

Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate

The NM_000157.4(GBA1):​c.1279G>T​(p.Glu427*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★). Synonymous variant affecting the same amino acid position (i.e. E427E) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.

Frequency

Genomes: not found (cov: 30)

Consequence

GBA1
NM_000157.4 stop_gained

Scores

6
2
6

Clinical Significance

Likely pathogenic criteria provided, single submitter P:1

Conservation

PhyloP100: 1.69

Publications

20 publications found
Variant links:
Genes affected
GBA1 (HGNC:4177): (glucosylceramidase beta 1) This gene encodes a lysosomal membrane protein that cleaves the beta-glucosidic linkage of glycosylceramide, an intermediate in glycolipid metabolism. Mutations in this gene cause Gaucher disease, a lysosomal storage disease characterized by an accumulation of glucocerebrosides. A related pseudogene is approximately 12 kb downstream of this gene on chromosome 1. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2010]
GBA1 Gene-Disease associations (from GenCC):
  • Parkinson disease
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • Gaucher disease
    Inheritance: AR Classification: DEFINITIVE Submitted by: Myriad Women’s Health, ClinGen
  • Gaucher disease perinatal lethal
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Laboratory for Molecular Medicine, Genomics England PanelApp
  • late-onset Parkinson disease
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • Gaucher disease type I
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet
  • Gaucher disease type II
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp
  • Gaucher disease type III
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet
  • Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 12 ACMG points.

PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 1-155235790-C-A is Pathogenic according to our data. Variant chr1-155235790-C-A is described in ClinVar as Likely_pathogenic. ClinVar VariationId is 505377.Status of the report is criteria_provided_single_submitter, 1 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GBA1NM_000157.4 linkc.1279G>T p.Glu427* stop_gained Exon 9 of 11 ENST00000368373.8 NP_000148.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GBA1ENST00000368373.8 linkc.1279G>T p.Glu427* stop_gained Exon 9 of 11 1 NM_000157.4 ENSP00000357357.3

Frequencies

GnomAD3 genomes
Cov.:
30
GnomAD4 exome
Cov.:
32
GnomAD4 genome
Cov.:
30
Alfa
AF:
0.00
Hom.:
1
Bravo
AF:
0.00000378

ClinVar

Significance: Likely pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Gaucher disease Pathogenic:1
Nov 21, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.Glu427X variant in GBA has not been previously reported in patients with G aucher disease and was absent from large population studies. This nonsense varia nt leads to a premature termination codon at position 427, which is predicted to lead to a truncated or absent protein. Biallelic mutations (including loss of f unction) in the GBA gene cause Gaucher disease. In summary, this variant meets c riteria to be classified as likely pathogenic for Gaucher disease in an autosoma l recessive manner based upon predicted null effect. Please note that, due to th e technical limitations of the next generation sequencing and Sanger confirmatio n assays, the GBA pseudogene cannot be reliably avoided. Therefore, before makin g clinical decisions regarding this variant, further testing via targeted assays that guarantee avoidance of GBA pseudogene would be required to confirm the pre sence of this variant.

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.63
D
BayesDel_noAF
Pathogenic
0.59
CADD
Pathogenic
36
DANN
Uncertain
1.0
DEOGEN2
Benign
0.0
.;.;.;.
Eigen
Pathogenic
0.84
Eigen_PC
Pathogenic
0.68
FATHMM_MKL
Uncertain
0.95
D
LIST_S2
Benign
0.0
.;.;.;.
MetaRNN
Benign
0.0
.;.;.;.
MutationAssessor
Benign
0.0
.;.;.;.
PhyloP100
1.7
PROVEAN
Benign
0.0
.;.;.;.
REVEL
Benign
0.0
Sift
Pathogenic
0.0
.;.;.;.
Sift4G
Pathogenic
0.0
.;.;.;.
Vest4
0.87
GERP RS
5.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=0/200
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs149171124; hg19: chr1-155205581; API